Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Axcella Health Inc.
Headquarters: Cambridge, MA, United States of America
Website: http://www.axcellahealth.com...
Year Founded: 2008
Status: Public
Industry Sector: HealthTechnology
CEO: Craig R. Jalbert
Number Of Employees: 11
Enterprise Value: $2,815,510
PE Ratio: -0.02
Exchange/Ticker 1: NASDAQ:AXLA
Exchange/Ticker 2: N/A
Latest Market Cap: $1,181,700
BioCentury | Jun 7, 2024
Management Tracks
Boston Pharma names Margaret Koziel CMO
Plus: Phillip Dennis joins I-Mab as CMO, and an update from Exscientia
BioCentury | Feb 29, 2024
Management Tracks
William Hinshaw to lead Fore
Plus: Luigi Costa passes away and updates from Corbus, Bexion, ADMA and more
BioCentury | Dec 6, 2023
Deals
Dec. 5 Quick Takes: Nearing clinic, Odyssey raises $101M series C
Plus: Genentech PI3K combo meets PFS endpoint in Phase III and more from ImmunoGen, SpringWorks, Eligo, BrainChild, Axcella, Sanofi, Aqemia and IGM
BioCentury | Feb 23, 2023
Product Development
Novartis CMO sees new FDA directives pushing biotechs to pharma deals
Shreeram Aradhye tells The BioCentury Show clinical trial requirements on dose, diversity will seed the ground for earlier partnering
BioCentury | Sep 29, 2022
Deals
Sept. 29 Quick Takes: New life for Idera via Aceragen acquisition
Plus Biohaven’s verdiperstat misses again and updates from Meliora, Sarepta and more
BioCentury | Aug 3, 2022
Finance
Aug. 2 Quick Takes: Yescarta label expansion buoys Gilead’s 2Q22 sales
Plus Megaround for Sironax, and updates from Eleven, Roche, Axcella, Phathom, and more
BioCentury | Mar 6, 2021
Management Tracks
Winter to lead BeiGene’s European commerical ops; plus Dyne, Axcella, Prometheus and more
BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) hired Gerwin Winter as SVP and head of commercial for Europe. Winter was previously SVP and head of Europe at Portola Pharmaceuticals Inc. before its acquisition
BioCentury | Aug 31, 2020
Deals
Takeout premium shows Nestlé’s faith in Aimmune peanut product, despite launch slowed by COVID
Nestlé Health Science’s premium-priced takeout of peanut allergy company Aimmune is its biggest move yet in biotech, giving it full control of a marketed program in which the nutrition
BioCentury | Aug 8, 2020
Management Tracks
PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more
BioCentury | Aug 7, 2020
Management Tracks
First chief diversity officer for Alexion; plus changes at WuXi, Dicerna, Valneva, MeiraGTx, Anika and more
Items per page:
1 - 10 of 28